We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+21.19%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.77B
AUM Growth
-$20M
Cap. Flow
-$279M
Cap. Flow %
-15.76%
Top 10 Hldgs %
16.25%
Holding
547
New
90
Increased
94
Reduced
221
Closed
118

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$32.2M
2
A icon
Agilent Technologies
A
+$10.1M
3
INCY icon
Incyte
INCY
+$9.9M
4
APC
Anadarko Petroleum
APC
+$9.65M
5
NOW icon
ServiceNow
NOW
+$9.61M

Top Sells

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$22.6M
2
AGN
Allergan plc
AGN
+$19.6M
3
CPRI icon
Capri Holdings
CPRI
+$18.6M
4
DAL icon
Delta Air Lines
DAL
+$17.6M
5
NTNX icon
Nutanix
NTNX
+$17.6M

Sector Composition

Rank Sector Weight
1 Healthcare 26.83%
2 Technology 24.23%
3 Consumer Discretionary 14.95%
4 Industrials 7.4%
5 Financials 7.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NSIT icon
251
Insight Enterprises
NSIT
$3.71B
$1.12M 0.06%
20,300
-11
-0.1% -$555
SSTK icon
252
Shutterstock
SSTK
$216M
$1.1M 0.06%
23,600
-6,846
-22% -$289K
MOV icon
253
Movado Group
MOV
$835M
$1.09M 0.06%
30,045
+4,912
+20% +$165K
WLH
254
DELISTED
WILLIAM LYON HOMES
WLH
$1.09M 0.06%
71,069
-33,404
-32% -$461K
GOOS
255
Canada Goose Holdings
GOOS
$891M
$1.08M 0.06%
22,575
-6,078
-21% -$310K
FLXN
256
DELISTED
Flexion Therapeutics, Inc.
FLXN
$1.08M 0.06%
+86,262
New +$1.15M
BTE icon
257
Baytex Energy
BTE
$2.94B
$1.02M 0.06%
600,028
-181,539
-23% -$318K
NTRA icon
258
Natera
NTRA
$37B
$1.01M 0.06%
+49,244
New +$771K
LKFN icon
259
Lakeland Financial Corp
LKFN
$1.58B
$998K 0.06%
22,076
+676
+3% +$30.8K
LAB icon
260
Standard BioTools
LAB
$303M
$994K 0.06%
74,800
+40,150
+116% +$423K
AKRX
261
DELISTED
Akorn Inc
AKRX
$994K 0.06%
282,300
+27,200
+11% +$104K
ERIE icon
262
Erie Indemnity
ERIE
$11.9B
$982K 0.06%
+5,503
New +$884K
WMS icon
263
Advanced Drainage Systems
WMS
$11B
$966K 0.05%
37,500
+7,000
+23% +$177K
RLI icon
264
RLI Corp
RLI
$5.88B
$961K 0.05%
26,800
-5,488
-17% -$189K
WOR icon
265
Worthington Enterprises
WOR
$2.79B
$955K 0.05%
41,523
-11,849
-22% -$271K
LXRX icon
266
Lexicon Pharmaceuticals
LXRX
$991M
$952K 0.05%
171,246
+16,745
+11% +$102K
CSII
267
DELISTED
Cardiovascular Systems, Inc.
CSII
$943K 0.05%
24,400
– –
AMAG
268
DELISTED
AMAG Pharmaceuticals
AMAG
$927K 0.05%
72,000
– –
WVE icon
269
Wave Life Sciences
WVE
$1.14B
$901K 0.05%
23,190
+7,090
+44% +$288K
SCS
270
DELISTED
Steelcase
SCS
$900K 0.05%
61,887
+84
+0.1% +$1.4K
CIGI icon
271
Colliers International
CIGI
$5.21B
$860K 0.05%
12,869
+3,394
+36% +$217K
MGEE icon
272
MGE Energy Inc
MGEE
$3.08B
$847K 0.05%
12,462
– –
NVMI
273
Nova
NVMI
$13.6B
$844K 0.05%
33,500
-3,800
-10% -$92.1K
FSV icon
274
FirstService
FSV
$6.45B
$806K 0.05%
9,033
-1,008
-10% -$82.8K
CNNE icon
275
Cannae Holdings
CNNE
$650M
$801K 0.05%
33,000
-9,580
-22% -$202K
9 10
11
12 13

Similar funds

ISS
Intesa Sanpaolo SpA. Turin, Italy $1.69B AUM
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
FACM
Forest Avenue Capital Management Miami, Florida $1.69B AUM 104.84% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
WAS
Wesleyan Assurance Society Birmingham, United Kingdom $1.69B AUM 28.38% 1-Year Est. Return
SGI
Summit Global Investments Bountiful, Utah $1.69B AUM 12.13% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

PDT Partners's Q1 2019 Portfolio in Review

As of Q1 2019, PDT Partners held 547 positions worth $1.77B, down 1.1% from $1.79B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

PDT Partners withdrew a net $279M in Q1 2019, closing 118 positions and reducing 221 holdings. Its most notable exit was Morgan Stanley, an estimated $22.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 25% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, PDT Partners opened a new position in Bristol-Myers Squibb worth $30.8M.

  • PDT Partners's largest Q1 2019 buy was Bristol-Myers Squibb: 645,994 shares worth $30.8M.
  • PDT Partners added most to Anadarko Petroleum in Q1 2019, an estimated $9.65M increase.
  • PDT Partners's biggest Q1 2019 reduction was Spark Therapeutics, Inc. Common Stock, cutting an estimated $11.6M.
  • PDT Partners fully exited Morgan Stanley in Q1 2019, selling an estimated $22.6M.
  • PDT Partners's ten largest holdings make up 16% of its $1.77B portfolio in Q1 2019.
  • PDT Partners opened 90 new positions and closed 118 in Q1 2019.
  • PDT Partners's portfolio value fell 1.1% quarter-over-quarter to $1.77B.

Based on PDT Partners's 13F filing for Q1 2019, filed 15 May 2019.